The American Health Care Authorities have cleared Ambu's single-use videoscope, Ambu® aScope™

Ambu has been granted the 510K clearance for the Ambu® aScope™ by the American
health care authorities (Food and Drug Administration-FDA. The Ambu® aScope™
consists of two parts, the single-use videoscope and a monitor. 

With this clearance, the products, which were launched in the European market
around New Year 2009, can now be launched, marketed and sold in the American
market. 



Further information:
Lars Marcher, CEO, phone +45 5136 2490, e-mail: lm@ambu.com